文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在轻度退行性颈脊髓病(DCM)患者上肢残疾和功能障碍的量化中,症状持续时间。

Duration of symptoms in the quantification of upper limb disability and impairment for individuals with mild degenerative cervical myelopathy (DCM).

机构信息

Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.

Department of Physical Therapy, University of Toronto, Toronto, Ontario, Canada.

出版信息

PLoS One. 2019 Sep 9;14(9):e0222134. doi: 10.1371/journal.pone.0222134. eCollection 2019.


DOI:10.1371/journal.pone.0222134
PMID:31498813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6733515/
Abstract

OBJECTIVES: Degenerative cervical myelopathy (DCM) involves spinal cord compression, which causes neurological decline. Neurological impairment in DCM is variable and can involve complex upper limb dysfunction including loss of manual dexterity, hyper-reflexia, focal weakness, and sensory impairment. DCM can cause progressive loss of manual dexterity, reduced upper limb (UL) function and disability. The purpose of this study was to define relationships between impairment and disability of the UL and determine the impact of duration of symptoms on disease severity. DESIGN: An observational cross-sectional study quantifying disease severity, UL impairment and disability at time of diagnosis was conducted. A second observational longitudinal cohort was studied at the time of diagnosis and 1 year later. SETTING: Toronto Western Hospital, Spine Program. SUBJECTS: The cross sectional study included 140 study subjects diagnosed with mild, moderate or severe DCM. For the longitudinal study, 61 study subjects with mild DCM were enrolled and split into two groups, one group with less than 12 months of symptom duration and more than 12 months. MAIN MEASURES: Modified Japanese Orthopaedic Assessment (mJOA); Graded Redefined Assessment of Sensation, Strength and Prehension (GRASSP); Quick Disability of the Arm, Shoulder and Hand (QuickDASH). RESULTS: Pearson correlation coefficients between GRASSP and QuickDASH revealed significant relationships between strength, sensation and dexterity for all patients to varying degrees. The covariate (mJOA) was significantly related to QuickDASH, indicating duration of symptoms has an important effect on UL disability in the mild severity group. CONCLUSIONS: Strength, sensation and dexterity play a defining role in disability of the UL across all severities of DCM and are discriminant measures. Duration of symptoms has a significant impact on self-perceived disability, where a longer duration in mild patients results in diminished disability, suggesting adaptation. Duration of symptoms is an important factor to consider in the treatment plan for patients with mild disease.

摘要

目的:退行性颈脊髓病(DCM)涉及脊髓压迫,导致神经功能下降。DCM 的神经损伤是多变的,可能涉及复杂的上肢功能障碍,包括手的灵巧度丧失、反射亢进、局灶性无力和感觉障碍。DCM 可导致手的灵巧度进行性丧失、上肢(UL)功能和活动能力下降。本研究的目的是确定 UL 损伤和残疾与疾病严重程度之间的关系,并确定症状持续时间对疾病严重程度的影响。

设计:本研究采用观察性横断面研究,对诊断时的疾病严重程度、UL 损伤和残疾进行了量化。对第二个观察性纵向队列在诊断时和 1 年后进行了研究。

地点:多伦多西部医院,脊柱项目。

受试者:横断面研究包括 140 名被诊断为轻度、中度或重度 DCM 的研究对象。对于纵向研究,招募了 61 名轻度 DCM 研究对象,并将其分为两组,一组症状持续时间少于 12 个月,另一组持续时间超过 12 个月。

主要测量指标:改良日本骨科评估量表(mJOA);重新定义的感觉、力量和抓握分级评估(GRASSP);手臂、肩部和手部快速残疾(QuickDASH)。

结果:GRASSP 与 QuickDASH 之间的 Pearson 相关系数显示,所有患者的力量、感觉和灵巧度之间存在显著关系,程度不同。协变量(mJOA)与 QuickDASH 显著相关,表明在轻度严重程度组,症状持续时间对 UL 残疾有重要影响。

结论:在所有 DCM 严重程度中,力量、感觉和灵巧度在 UL 残疾中起着决定性作用,是有区别的测量指标。症状持续时间对手部残疾有显著影响,轻度患者的症状持续时间较长,残疾程度降低,提示适应性。症状持续时间是治疗轻度疾病患者的重要考虑因素。

相似文献

[1]
Duration of symptoms in the quantification of upper limb disability and impairment for individuals with mild degenerative cervical myelopathy (DCM).

PLoS One. 2019-9-9

[2]
Characteristics of Upper Limb Impairment Related to Degenerative Cervical Myelopathy: Development of a Sensitive Hand Assessment (Graded Redefined Assessment of Strength, Sensibility, and Prehension Version Myelopathy).

Neurosurgery. 2020-3-1

[3]
Degenerative cervical myelopathy: establishing severity thresholds for neuromotor dysfunction in the aging spine using the NIH Toolbox Assessment Scale.

Geroscience. 2024-4

[4]
Classifying Hand Dexterity Impairment in Degenerative Cervical Myelopathy With 10-Second Grip and Release Test.

Spine (Phila Pa 1976). 2024-4-1

[5]
Defining the role of sensation, strength, and prehension for upper limb function in cervical spinal cord injury.

Neurorehabil Neural Repair. 2013-6-18

[6]
Clinical outcomes of nonoperatively managed degenerative cervical myelopathy: an ambispective longitudinal cohort study in 117 patients.

J Neurosurg Spine. 2021-4-9

[7]
Is Preoperative Duration of Symptoms a Significant Predictor of Functional Outcomes in Patients Undergoing Surgery for the Treatment of Degenerative Cervical Myelopathy?

Neurosurgery. 2019-11-1

[8]
Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy.

Spine (Phila Pa 1976). 2013-10-15

[9]
Early neurological changes in aging cervical spine: insights from PROMIS mobility assessment.

Geroscience. 2024-6

[10]
Inter-rater Reliability of the Modified Japanese Orthopedic Association Score in Degenerative Cervical Myelopathy: A Cross-sectional Study.

Spine (Phila Pa 1976). 2021-8-15

引用本文的文献

[1]
Subclinical knee extensor weakness predicts gait and balance impairment in degenerative cervical myelopathy.

Geroscience. 2025-9-6

[2]
Machine learning algorithms for prediction of cerebrospinal fluid leakage after posterior surgery for thoracic ossification of the ligamentum flavum.

Sci Rep. 2025-7-3

[3]
Duration of symptoms before diagnosis in degenerative cervical myelopathy: A systematic review and meta-analysis.

Brain Spine. 2025-4-16

[4]
Intramedullary Stress and Strain Correlate with Neurological Dysfunction in Degenerative Cervical Myelopathy.

Appl Sci (Basel). 2025-1

[5]
Posterior Decompression and Fixation for Thoracic Spine Ossification: A 10-Year Follow-Up Study.

J Clin Med. 2023-9-1

[6]
Improving Assessment of Disease Severity and Strategies for Monitoring Progression in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 4].

Global Spine J. 2022-2

[7]
Degenerative cervical myelopathy presenting as subjective lower limb weakness could be a trap towards misdiagnosis.

Sci Rep. 2020-12-3

[8]
Provision and Perception of Physiotherapy in the Nonoperative Management of Degenerative Cervical Myelopathy (DCM): A Cross-Sectional Questionnaire of People Living With DCM.

Global Spine J. 2022-5

本文引用的文献

[1]
Monitoring for myelopathic progression with multiparametric quantitative MRI.

PLoS One. 2018-4-17

[2]
A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.

Global Spine J. 2017-9

[3]
The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy.

Eur Spine J. 2017-1

[4]
Cervical spondylotic myelopathy: an update: editorial.

Eur Spine J. 2015-4

[5]
A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study.

J Bone Joint Surg Am. 2013-9-18

[6]
Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study.

J Bone Joint Surg Am. 2013-9-18

[7]
Diagnosis, heritability, and outcome assessment in cervical myelopathy: a consensus statement.

Spine (Phila Pa 1976). 2013-10-15

[8]
Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy.

Spine (Phila Pa 1976). 2013-10-15

[9]
Defining the role of sensation, strength, and prehension for upper limb function in cervical spinal cord injury.

Neurorehabil Neural Repair. 2013-6-18

[10]
Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder.

Neuroscientist. 2012-11-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索